CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy

Jong Keon Jang(Ulsan College), Moon-Gyu Lee(Ulsan College), Jae Ho Byun(University of Ulsan), Seung Soo Lee(Asan Medical Center), Seung‐Mo Hong(Ulsan College), Song Cheol Kim(Ulsan College), Hyoung Jung Kim(University of Ulsan), Changhoon Yoo(Ulsan College), Jung Hee Son(Ulsan College), Jin Hee Kim(University of Ulsan), Dong‐Wan Seo(Ulsan College), Ji Hun Kang(Ulsan College), Kyu‐pyo Kim(Ulsan College)
European Radiology
August 26, 2020
10.1007/s00330-020-07188-8
Cited by 44

Related Papers

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2023|1.1k
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472